Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Vargas, SO; French, CA; Faul, PN; Fletcher, JA; Davis, IJ; Dal Cin, P; Perez-Atayde, AR
   Upper respiratory tract carcinoma with chromosomal translocation 15;19 - Evidence for a distinct disease entity of young patients with a rapidly fatal course
   CANCER
   
   S.O. Vargas et al., "Upper respiratory tract carcinoma with chromosomal translocation 15;19 - Evidence for a distinct disease entity of young patients with a rapidly fatal course", CANCER, 92(5), 2001, pp. 1195-1203
2. French, CA; Miyoshi, I; Aster, JC; Kubonishi, I; Kroll, TG; Dal Cin, P; Vargas, SO; Perez-Atayde, AR; Fletcher, JA
   BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)
   AMERICAN JOURNAL OF PATHOLOGY
   
   C.A. French et al., "BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19)", AM J PATH, 159(6), 2001, pp. 1987-1992
3. French, CA; Dorfman, DM; Shaheen, G; Cibas, ES
   Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: Increased sensitivity using flow cytometric analysis
   DIAGNOSTIC CYTOPATHOLOGY
   
   C.A. French et al., "Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: Increased sensitivity using flow cytometric analysis", DIAGN CYTOP, 23(6), 2000, pp. 369-374
4. French, CA; Mentzel, T; Kutzner, H; Fletcher, CDM
   Intradermal spindle cell/pleomorphic lipoma - A distinct subset
   AMERICAN JOURNAL OF DERMATOPATHOLOGY
   
   C.A. French et al., "Intradermal spindle cell/pleomorphic lipoma - A distinct subset", AM J DERMAT, 22(6), 2000, pp. 496-502
5. Lambert-Messerlian, GM; Saller, DN; Tumber, MB; French, CA; Peterson, CJ; Canick, JA
   Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18
   PRENATAL DIAGNOSIS
   
   G.M. Lambert-Messerlian et al., "Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18", PRENAT DIAG, 19(5), 1999, pp. 476-479
6. LAMBERTMESSERLIAN GM; SALLER DN; TUMBER MB; FRENCH CA; PETERSON CJ; CANICK JA
   2ND-TRIMESTER MATERNAL SERUM INHIBIN-A LEVELS IN FETAL TRISOMY-18 ANDTURNER-SYNDROME WITH AND WITHOUT HYDROPS
   Prenatal diagnosis
   
   G.M. Lambertmesserlian et al., "2ND-TRIMESTER MATERNAL SERUM INHIBIN-A LEVELS IN FETAL TRISOMY-18 ANDTURNER-SYNDROME WITH AND WITHOUT HYDROPS", Prenatal diagnosis, 18(10), 1998, pp. 1061-1067
7. FRENCH CA; BIEBER FR; BING DH; GENEST DR
   TWINS, PLACENTAS, AND GENETICS - ACARDIAC TWINNING IN A DICHORIONIC DIAMNIOTIC, MONOZYGOTIC TWIN GESTATION
   Human pathology
   
   C.A. French et al., "TWINS, PLACENTAS, AND GENETICS - ACARDIAC TWINNING IN A DICHORIONIC DIAMNIOTIC, MONOZYGOTIC TWIN GESTATION", Human pathology, 29(9), 1998, pp. 1028-1031
8. RAHUELCLERMONT S; FRENCH CA; CHOU CI; KAARSHOLM NC; DUNN MF
   MECHANISMS OF STABILIZATION OF THE INSULIN HEXAMER THROUGH ALLOSTERICLIGAND INTERACTIONS (VOL 36, PG 5837, 1997)
   Biochemistry
   
   S. Rahuelclermont et al., "MECHANISMS OF STABILIZATION OF THE INSULIN HEXAMER THROUGH ALLOSTERICLIGAND INTERACTIONS (VOL 36, PG 5837, 1997)", Biochemistry, 36(32), 1997, pp. 9950-9950
9. RAHUELCLERMONT S; FRENCH CA; KAARSHOLM NC; DUNN MF
   MECHANISMS OF STABILIZATION OF THE INSULIN HEXAMER THROUGH ALLOSTERICLIGAND INTERACTIONS
   Biochemistry
   
   S. Rahuelclermont et al., "MECHANISMS OF STABILIZATION OF THE INSULIN HEXAMER THROUGH ALLOSTERICLIGAND INTERACTIONS", Biochemistry, 36(19), 1997, pp. 5837-5845
10. SALLER DN; CANICK JA; KELLNER LH; ROSE NC; GARZA J; FRENCH CA; MOONEY RA
    MATERNAL SERUM ANALYTE LEVELS IN PREGNANCIES WITH FETAL DOWN-SYNDROMERESULTING FROM TRANSLOCATIONS
    American journal of obstetrics and gynecology
    
    D.N. Saller et al., "MATERNAL SERUM ANALYTE LEVELS IN PREGNANCIES WITH FETAL DOWN-SYNDROMERESULTING FROM TRANSLOCATIONS", American journal of obstetrics and gynecology, 177(4), 1997, pp. 879-881
11. LAMBERTMESSERLIAN GM; TUMBER MB; SALLER DN; FRENCH CA; PETERSON CJ; CANICK JA
    2ND-TRIMESTER LEVELS OF MATERNAL SERUM INHIBIN-A IN FETAL TRISOMY-18 AND IN TURNER-SYNDROME WITH AND WITHOUT HYDROPS
    American journal of human genetics
    
    G.M. Lambertmesserlian et al., "2ND-TRIMESTER LEVELS OF MATERNAL SERUM INHIBIN-A IN FETAL TRISOMY-18 AND IN TURNER-SYNDROME WITH AND WITHOUT HYDROPS", American journal of human genetics, 61(4), 1997, pp. 891-891
12. MOONEY RA; ARVAN DA; SALLER DN; FRENCH CA; PETERSON CJ
    DECREASED MATERNAL SERUM HCG LEVELS WITH INCREASING GRAVIDITY AND PARITY
    Obstetrics and gynecology
    
    R.A. Mooney et al., "DECREASED MATERNAL SERUM HCG LEVELS WITH INCREASING GRAVIDITY AND PARITY", Obstetrics and gynecology, 86(6), 1995, pp. 900-905
13. FRENCH CA; HIGGINS PD; RIZZO GT
    THE APPLICATION OF QUALITY INDICATORS TO COST-EFFECTIVENESS IN THE HOSPITAL LABORATORY
    Clinical chemistry
    
    C.A. French et al., "THE APPLICATION OF QUALITY INDICATORS TO COST-EFFECTIVENESS IN THE HOSPITAL LABORATORY", Clinical chemistry, 41(6), 1995, pp. 207-207
14. MOONEY RA; FRENCH CA; SALLER DN; PETERSON CJ; ARVAN DA
    TRENDS IN MATERNAL SERUM MARKERS IN SUCCESSIVE PREGNANCIES SUGGEST ADDITIONAL MATERNAL FACTORS INFLUENCE LEVELS
    American journal of human genetics
    
    R.A. Mooney et al., "TRENDS IN MATERNAL SERUM MARKERS IN SUCCESSIVE PREGNANCIES SUGGEST ADDITIONAL MATERNAL FACTORS INFLUENCE LEVELS", American journal of human genetics, 57(4), 1995, pp. 1656-1656
15. MOONEY RA; PETERSON CJ; FRENCH CA; SALLER DN; ARVAN DA
    EFFECTIVENESS OF COMBINING MATERNAL SERUM ALPHA-FETOPROTEIN AND HCG IN A 2ND-TRIMESTER SCREENING-PROGRAM FOR DOWN-SYNDROME
    Obstetrics and gynecology
    
    R.A. Mooney et al., "EFFECTIVENESS OF COMBINING MATERNAL SERUM ALPHA-FETOPROTEIN AND HCG IN A 2ND-TRIMESTER SCREENING-PROGRAM FOR DOWN-SYNDROME", Obstetrics and gynecology, 84(2), 1994, pp. 298-303
16. MOONEY RA; PETERSON CJ; FRENCH CA; SALLER DN; ARVAN DA
    EFFECTIVENESS OF COMBINING MATERNAL SERUM AFP AND HUMAN CHORIONIC-GONADOTROPIN IN A 2ND TRIMESTER SCREENING-PROGRAM FOR DOWN-SYNDROME
    American journal of human genetics
    
    R.A. Mooney et al., "EFFECTIVENESS OF COMBINING MATERNAL SERUM AFP AND HUMAN CHORIONIC-GONADOTROPIN IN A 2ND TRIMESTER SCREENING-PROGRAM FOR DOWN-SYNDROME", American journal of human genetics, 53(3), 1993, pp. 1440-1440